An in silico Method to developing an epitope-based peptide vaccination against SARS-CoV-2's Envelope Protein (E)
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Päätekijä: | Intesar, Mohammad Nafees |
---|---|
Muut tekijät: | Siam, Mohammad Kawsar Sharif |
Aineistotyyppi: | Opinnäyte |
Kieli: | English |
Julkaistu: |
Brac University
2023
|
Aiheet: | |
Linkit: | http://hdl.handle.net/10361/17754 |
Samankaltaisia teoksia
-
In-silico based vaccine development: targeting nucleocapsid protein of SARS-CoV-2.
Tekijä: Iva, Yesmine Akter
Julkaistu: (2022) -
An in Silico approach to multi-epitope subunit vaccine development against SARS COV-2 using Membrane Glycoprotein
Tekijä: Rafsan, Rian
Julkaistu: (2021) -
Omicron, delta, and beta, deadliest among SARS-CoV-2 variants: an in silico analysis
Tekijä: Bosu, Sagar
Julkaistu: (2023) -
Overview of the risk factors, prevention and management of SARS-COV-2
Tekijä: Mustafa, Nashrah
Julkaistu: (2021) -
Developing a novel multi-epitope vaccine against Dengue virus targeting the Envelope protein using an Immunoinformatics approach
Tekijä: NASIFUZZAMAN, S M
Julkaistu: (2021)